Treatment of allergic rhinitis using a combination of mometasone and olopatadine

US10016443B2 · kind B2 · utility

Assignee

• GLENMARK SPECIALTY S.A. · CH

Inventors

• Neelima Khairatkar-Joshi · Thane, IN
• Abhay Kulkarni · Navi Mumbai, IN
• Pradeep D. Wale · Tuljapur, IN
• Vikram M. Bhosale · Mumbai, IN
• Piyush Agarwal · Mumbai, IN
• Patrick Keohane · London, GB
• Sudeesh K. Tantry · Jamison, US
• Chad Oh · San Francisco, US

Key dates

• Filing date: Jun 28, 2017
• Grant date: Jul 10, 2018
• Expiry date: Jun 28, 2037

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/58
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a human) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.